Inherited Disorders Of Amino Acid Catabolism Flashcards

1
Q

What is the significance of inherited disorders of amino acid catabolism?

A
  • Enzyme deficiencies involved in amino acid metabolism result in accumulation of toxic substances
  • Greater enzyme deficiencies = increased toxicity
  • Brain, liver and kidneys most affected
  • Acute symptoms typically during catabolic state

• Most aminoacidopathies are identified by newborn screening
“The day after being discharged from the hospital the parents of a new-born baby receive an emergency phone call telling them to not feed their baby, but to report to their physician immediately”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the disorders of amino acid catabolism

A

Phenylalanine and Tyrosine
- Phenylketonuria, albinism, alkaptonuria, tyrosinosis

Branched chain amino acids (Valine, isoleucine, leucine)
- Maple syrup urine disease, methylmalonic aciduria

Sulfur containing amino acids (Methionine and cysteine)
- Homocystinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does mass. Spectrometry work?

A
  • Amino acid concentration in blood quantitated from blood spot
  • Other organic molecules can also be quantitated from blood spot
  • Molecular profile based upon the mass / charge ratio of the fractured molecule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is phenylketonuria?

A
  • Relatively common of the rare disorders
  • Autosomal recessive disorder

• Responds very well to dietary treatment
Phenylalanine

  • Detected during the first week of life by neonatal screening:
    • The Guthrie test (historical)
  • Mass Spec (current use)
  • If test is positive
  • Immediately - place infant on low Phenylalanine (Phe) diet
  • Then - test again, in case of false positive
  • Some centers test infants twice
  • First test might be false negative due to maternal clearance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does phenylketonuria affect children?

A
  • Children confirmed to have PKU, have to be put on a low Phe diet
  • Medical food that is modified to have low Phe
  • Low protein diet
  • Avoid aspartame (artificial sweetener; i.e., Diet Coke, etc)
  • Dietary restriction of Phe to be started immediately on diagnosis
  • Blood Phe levels have to be frequently monitored
  • If treated, children lead a normal life
    • Except for the dietary restrictions

• Recommended lifelong adherence, but after development, patients often stray from the diet (not recommended)
• First successfully treated inborn error of metabolism by dietary
restriction was in the 1950s (Bickel, 1953

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the defect in PKU I

A

This is classic PAH is absent and cannot convert phenylalanine to tyrosine

Phenylaline still converted to phenylpyruvic acid —>phenylpyruvic acid excreted in urine (mousey odor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the characteristics of PKU I (classic PKU) in untreated patients?

A
  • CNS symptoms: child has a delay in milestones and a low IQ (if not treated immediately). Seizures if blood Phe are higher than the recommended level
  • Phe is metabolized to phenylpyruvate, phenylacetate & phenyllactate (excreted in urine) resulting in mousey odor of urine
  • Phe levels in blood are elevated
  • Decreased pigmentation of skin and hair as tyrosine conversion to melanin is inhibited by the elevated Phe levels (inhibits tyrosinase)

Most untreated patients have lighter coloring then parents/siblings from reduced melanin synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What were the symptoms of PKU nefore tratm3nt 2as known?

A
  • Intellectual disability
  • Seizures
  • Spasticity
  • Autistic behaviors
  • Hypopigmentation
  • Skin rashes

The sibling treated at birth develops normally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is PKU treated?

A

• Avoidance – dietary treatment – reduction in phenylalanine (careful monitoring of Phe intake during growth of the patient)

  • Sapropterin (synthetic form of BH4) may help some PKU patients
  • Typically mild or moderate forms of the disease
  • These patients may have a mutant form of the enzyme that has a lower affinity for the cofactor qBH2/BH4
  • Considered the first non-dietary treatment for PKU
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe maternal PKU syndrome

A

Women with PKU must maintain low Phe levels
before conception and during pregnancy.
• Strict adherence must be maintained prior to conception and throughout pregnancy

  • High maternal blood Phe leads to fetal defects:
    • Microcephaly
    • Lack of mental development, severe neurological problems
    • Congenital heart defects
    • Facial dysmorphology- long philtrum, epicanthal folds, micrognathia, short nose, microphthalmia, flat midface, facies similar to fetal alcohol syndrome
  • Elevated phenylalanine has teratogenic properties
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most people are…

A

homozygous for normal alleles of PAH gene

Offspring of a person with PKU
All children, once born, will be normal (heterozygous). But during fetal development, the high circulating levels of maternal serum PHE would be teratogenic if the mother is not under strict dietary control of phenylalanine consumption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What causes alkaptonuria?

A
  • Relatively benign inborn error of phenylalanine - tyrosine catabolism
  • Deficiency in Homogentisic Acid Oxidase
  • Homogentisic acid accumulates, may lead to severe arthritis later in life
  • Dietary restriction of Phe & Tyrosine may reduce deposition of homogentisic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the symptoms of alkaptonuria?

A

– Darkening of urine on standing

– Discoloration of cartilage and connective tissue

– Ochronotic pigments (ochronosis)

– Often leads to severe arthritis

– Due to oxidation of excess homogentisic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the effect of tyrosinemia type 1?

A
Build-up of fumarylacetoacetate 
• Causes kidney and liver damage
• Metabolized to another compounds 
• Contributes cabbage like smell to
urine
Nitisinone (NTBC) inhibits 4-OH-
phenylpyruvate dioxygenase (PDO) to
prevent accumulation of toxic metabolites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the cayses of tyrosinosis (tyrosinemia type 1)?

A
  • Inborn error of phenylalanine-tyrosine catabolism
  • Deficiency of fumarylacetoacetate hydrolase

• Manifestations are severe and usually fatal • Liver failure
• Renal failure
• Cabbage like odor of the urine
Nitisone

  • Dietary restriction of Phe & Tyr
    • Difficult to accomplish as two essential amino acids must be limited
    • Tyrosine is required for neurotransmitter synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What therapy can be done for tyrosinemia type 1/ tyrosinosis?

A
  • Therapy
  • Liver transplant (past)
  • Nitisinone available so liver transplantation not required for most patients
17
Q

Explain maple syrup urine disease

A
  • Inborn error of metabolism: branched chain amino acids
  • Mild to severe forms, relative to residual enzyme activity
  • Symptoms develop in neonates aged 3-5 days & must be treated immediately
  • Can be detected early in life by neonatal/newborn screening
  • Severe Form: Presents with poor feeding, vomiting, poor weight gain and increasing lethargy
18
Q

Contrast the forms of MSUD

A

Severe Form: Presents with poor feeding, vomiting, poor weight gain and increasing lethargy.
• Neurological signs (e.g., alternating muscular hypotonia and hypertonia, seizures, encephalopathy) develop rapidly.
• Ketosis and the characteristic odor of maple syrup in the urine are usually present when the first symptoms develop.
• Coma and death of the child in early infancy if not recognized and treated

• Mild Form: Psychomotor developmental delay, progressive neurological
disease, recurrent ketoacidotic episode

19
Q

What is the effect of defects in branch chained amino acids?

A

•Defect in BCK Dehydrogenase Complex causes MSUD
•Increases in ketoacids are neurotoxic, particularly
a-ketoisocaproic acid

•Ketoacid accumulation in urine responsible for maple syrup/burnt sugar odor

  • What cofactors might improve residual enzyme activity?
  • TPP
20
Q

How is MSUD treated?

A

• Acute: 20% glucose with insulin IV

• Long-term: Dietary restriction of branched chain amino acids (leucine,
isoleucine, valine) improves the neurological manifestations.
• Thiamine supplementation
• Very difficult to treat; requires lifelong restriction
• BCAA are very abundant in most protein sources
• The 3 BCAA are all essential
• Valine and isoleucine supplementation (recall -ketoisocaproic acid is most toxic)
• Avoidance of catabolic states: causes the mobilization of tissue protein which then releases amino acids

21
Q

Explain methylmalonyl CoA mutase deficiency

A

• Results in elevated levels of methylmalonic acid in circulation, found by GC/MS analysis on urine
• Causes metabolic acidosis due to the accumulation of methylmalonic acid • Ketosis and ketoacidosis
• Associated with neurological manifestations: seizures, encephalopathy
• Severity of disease is typically related to the amount of enzymatic activity •
Neonatal form
• Chronic intermittent form
• Chronic progressive form

22
Q

How is methylmalonyl CoA deficuency?

A

Treatment:
• May show improvement with vitamin B12 (cobalamin) supplementation if enzyme deficiency is due to a mutation in the B12 binding site of methylmalonyl CoA mutase

• Consider diet with reduced Isoleucine, Valine, Methionine, Threonine

23
Q

Describe the clinical signifucance of homocystinuria

A
  • A group of disorders in which there is a defect in homocysteine metabolism
  • Characterized by high plasma & urinary levels of homocysteine
  • Deficiency of cystathionine β-synthase (transulfuration pathway)
  • Homocysteine binds to connective tissue and disrupts its structure
  • Characterized by dislocation of lens (ectopia lentis), Skeletal abnormalities sometimes referred to as Marfanoid Habitus, Delay of mental development, premature arterial disease
  • Some patients respond to oral vitamin B6
24
Q

What are the fates of homocysteine reactions?

A

Methylation reactions
• Homocysteine is recycled to methionine by the activity of Methionine Synthase which has methylcobalamin as cofactor
• Methylcobalamin restored by 5-methyl THF
• Methyl group is donated to reactions

Transulfuration reactions
• Conversion of homocysteine to cystathionine by the activity cystathionine b-synthase (CBS) Synthase which has pyridoxal phosphate (PLP) as cofactor
• Cystathionine is converted to cysteine and homoserine, each is further metabolized

25
Q

What is the therapy of homocystinuria?

A
  • Pyridoxine (B6)
  • Restrict dietary protein
  • Supplement with methionine free medical food
  • Methionine supplementation in B6 unresponsive forms
  • Oral Betaine-HCl
25
Q

What is the therapy of homocystinuria?

A
  • Pyridoxine (B6)
  • Restrict dietary protein
  • Supplement with methionine free medical food
  • Methionine supplementation in B6 unresponsive forms
  • Oral Betaine-HCl
26
Q

How does homocysteine interferes with collagen?

A
  • Leads to lens dislocation after age 3
    • other ocular abnormalities as well
  • Osteoporosis develops during childhood, mental retardation
  • Lipid deposits form atheromas
  • Homocysteine can have other effects:
    • Lipid oxidation and platelet aggregation
    • leads to fibrosis
    • calcification of atherosclerotic plaque